The present invention is directed to a medicinal composition for treating skin inflammations, fungal/bacterial skin infections and related wounds, and also other skin wounds including those caused by burns. The cream also causes skin rejuvenation through an epithelisation process. The cream comprises Chitosan. Hydrocortisone acetate, Oxiconazole Nitrate and Fusidic acid. The invention also discloses a process to make the medicinal cream containing Fusidic Acid which is formed in situ from Sodium...

The present invention is directed to a medicinal composition for treating skin inflammations, fungal/bacterial skin infections and related wounds, and also other skin wounds including those caused by burns. The cream also causes skin rejuvenation through an epithelisation process. The cream comprises Chitosan. Fluticasone Propionate, Oxiconazole Nitrate and Fusidic acid. The invention also 10 discloses a process to make the medicinal cream containing Fusidic Acid which is formed in situ from Sod...

This invention relates to a method of treating otitis externa using a topical combination medication including one or more antifungal agent such as for example fluconazole voriconazole itraconazole clotrimazole amphotericin B caspofungin micafungin terbinafine naftifine butenafine amorolfine ravuconazole posaconazole flucytosine econazole enilaconazole miconazole oxiconazole saperconazole sulconazole terconazole tioconazole nikkomycin Z anidulafungin (LY303366) nystatin pimaricin griseofulvin ci...

This invention relates to a method of treating otitis externa using a topical combination medication including one or more antifungal agent such as for example fluconazole voriconazole itraconazole clotrimazole amphotericin B caspofungin micafungin terbinafine naftifine butenafine amorolfine ravuconazole posaconazole flucytosine econazole enilaconazole miconazole oxiconazole saperconazole sulconazole terconazole tioconazole nikkomycin Z anidulafungin (LY303366) nystatin pimaricin griseofulvin ci...

This invention relates to a method of treating otitis externa and in particular otitis externa of fungal etiology using topical medication including antifungal agents such as for example fluconazole voriconazole itraconazole clotrimazole amphotericin B caspofungin (Cancidas®) micafungin (Mycamine®) terbinafine naftifine butenafine amorolfine ravuconazole posaconazole flucytosine econazole enilaconazole miconazole oxiconazole saperconazole sulconazole terconazole tioconazole nikkomycin Z an...

The present invention provides methods and products for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling. The compounds useful according to the invention are derivatives of imidazoles that are antimycotics including clotrimazole miconazole econazole butoconazole oxiconazole and sulconazole. Such analogs are active in the methods of the invention despite the fact that they do not contain an imidazole group.

This invention relates to a method of treating otitis externa using a topical combination medication including one or more antifungal agent such as for example fluconazole voriconazole itraconazole clotrimazole amphotericin B caspofungin micafungin terbinafine naftifine butenafine amorolfine ravuconazole posaconazole flucytosine econazole enilaconazole miconazole oxiconazole saperconazole sulconazole terconazole tioconazole nikkomycin Z anidulafungin (LY303366) nystatin pimaricin griseofulvin ci...